Advertisement

Supply Chain



The U.S. is halting distribution of sotrovimab, a COVID-19 antibody made by GlaxoSmithKline and Vir Biotechnology, in regions where the omicron subvariant BA.2 has become dominant in response to data suggesting the treatment is ineffective against the strain. 

A congressional oversight subcommittee has opened an investigation into the FDA's regulation of the HeartWare Ventricular Assist Device, which was implanted into thousands of Americans after the agency identified safety issues with the heart pump, ProPublica reported March 23. 

U.S. Pharmacopeia, an independent scientific organization, released a medicine supply map aiming to build visibility and identify which pharmaceutical ingredients are vulnerable to shortages, the organization said March 16. 

Advertisement

Most Read

Advertisement
Advertisement